Lisa D. Earnhardt, President and CEO at Intersect ENT, Inc. (XENT), sold 20,000 shares at $28.37 ($567K) on 2017-10-16, disclosed to the SEC on 2017-10-17.
Open-market sale of $567k XENT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2024-03-04 | $82K | — | Filing → |
| ABT | SELL | 2023-03-02 | $190K | — | Filing → |
| ABT | SELL | 2022-03-02 | $223K | — | Filing → |